Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

AVAVA MIRIA General Use

NCT: NCT06868615 · RECRUITING

NCT IDNCT06868615
StatusRECRUITING
Start Date2024-09-11
Completion2027-12-30
SponsorAVAVA, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

A general protocol to treat a variety of dermatologic conditions and collect patient feedback. Primary outcome is the collection and analysis of patient questionnaires related to the overall experience of the device treatment. Secondary outcome measures include physician and subject evaluations in regards to improvement seen in the device as well as assessment of side effects.

Frequently Asked Questions

What is AVAVA MIRIA General Use?

AVAVA MIRIA General Use is a clinical trial registered under NCT06868615. Current status: RECRUITING.

What is the status of NCT06868615?

The current status of NCT06868615 (AVAVA MIRIA General Use) is: RECRUITING.

When did AVAVA MIRIA General Use start?

AVAVA MIRIA General Use started on 2024-09-11.

Related Devices

K223871Miria Skin Treatment SystemAVAVA, Inc. K202884SR-1 Skin Treatment SystemAVAVA, Inc. K213726PL-1 Skin Treatment SystemAVAVA, Inc. K221268SR-1 Skin Treatment SystemAVAVA, Inc. K250402AVAVA™ Skin Treatment SystemAVAVA, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑